Cold Spring Harbor Laboratory Executive and Leadership Team

John Tuke, the Chief Operating Officer at Cold Spring Harbor Laboratory, directs all internal business operations and infrastructure development. Overseeing the daily administrative functions of this non-profit biomedical research laboratory, the Chief Operating Officer ensures that scientific teams possess the necessary resources to conduct complex studies in cancer and neuroscience. This leadership role involves managing facility maintenance, human resources, and financial planning to support long-term institutional stability. By optimizing operational workflows, John Tuke directly impacts the efficiency of the research environment. Tuke maintains alignment between administrative support and the broader scientific mission, ensuring that the laboratory remains a premier destination for global research talent. Through rigorous oversight of internal systems, the Chief Operating Officer facilitates the seamless execution of high-stakes biomedical projects across the entire campus.

Charles Prizzi, the Senior VP, Advancement & Special To The Advisor & President at Cold Spring Harbor Laboratory, directs all philanthropic initiatives and strategic donor relations. Overseeing the expansion of funding channels, the Senior VP, Advancement & Special To The Advisor & President secures the capital required to sustain cutting-edge research in plant biology and quantitative biology. This leadership role involves cultivating partnerships with private foundations and individual donors to bolster the laboratory's financial foundation. By managing high-level outreach programs, Charles Prizzi directly impacts the ability of the institution to pursue ambitious scientific goals. Prizzi coordinates closely with the President to align fundraising efforts with the long-term vision of the organization. Through the development of robust advancement strategies, the Senior VP, Advancement & Special To The Advisor & President ensures the continued growth of the laboratory's research capabilities.

Morgan Browne, the President at Cold Spring Harbor Laboratory, directs the overarching strategic vision and scientific mission of the institution. Overseeing the integration of cancer, neuroscience, and plant biology research, the President ensures that the laboratory remains at the forefront of global biomedical innovation. This leadership role involves setting institutional priorities, guiding the Board of Trustees, and fostering a culture of academic excellence. By championing new research initiatives, Morgan Browne directly impacts the laboratory's influence within the international scientific community. Browne coordinates with other executive leaders to align operational, financial, and research goals with the core mission of the organization. Through the implementation of long-term growth strategies, the President drives the laboratory toward new discoveries that address critical challenges in human health and biology, maintaining the institution's status as a leader in quantitative biology.

Walter Goldschmidts, the Vice President and Executive Director, Office of Sponsored Programs at Cold Spring Harbor Laboratory, directs the acquisition and management of federal and private research grants. Overseeing the complex regulatory landscape of biomedical funding, the Vice President and Executive Director, Office of Sponsored Programs ensures compliance with all institutional and governmental standards. This leadership role involves navigating the intricacies of grant applications for cancer and neuroscience research, providing essential support to principal investigators. By streamlining the proposal process, Walter Goldschmidts directly impacts the laboratory's capacity to secure competitive funding. Goldschmidts maintains strong relationships with external funding agencies to facilitate the continuous flow of resources into the research pipeline. Through meticulous oversight of sponsored programs, the Vice President and Executive Director, Office of Sponsored Programs safeguards the financial integrity of the laboratory's diverse scientific portfolio.